img

Global Ketorolac Tromethamine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Ketorolac Tromethamine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Ketorolac tromethamine, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level.
Ketorolac Tromethamine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ketorolac Tromethamine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Short-term treatment of pain and Ophthalmic Surgery are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ketorolac Tromethamine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Ketorolac Tromethamine key manufacturers include Pfizer, Omeros Corporation, Egalet US Inc., Allergan, Dr. Reddy’s Laboratories, Teva, Mylan, West Ward Pharmaceuticals and Fresenius Kabi, etc. Pfizer, Omeros Corporation, Egalet US Inc. are top 3 players and held % sales share in total in 2022.
Ketorolac Tromethamine can be divided into Injection, Ophthalmic, Nasal and Oral tablet, etc. Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Ketorolac Tromethamine is widely used in various fields, such as Short-term treatment of pain and Ophthalmic Surgery, etc. Short-term treatment of pain provides greatest supports to the Ketorolac Tromethamine industry development. In 2022, global % sales of Ketorolac Tromethamine went into Short-term treatment of pain filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ketorolac Tromethamine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Omeros Corporation
Egalet US Inc.
Allergan
Dr. Reddy’s Laboratories
Teva
Mylan
West Ward Pharmaceuticals
Fresenius Kabi
Apotex
Sandoz
Amphastar Pharmaceuticals
Gland Pharma Limited
Akorn
Sun Pharmaceutical
Sagent Pharmaceuticals
Aurobindo Pharma
Segment by Type
Injection
Ophthalmic
Nasal
Oral tablet

Segment by Application


Short-term treatment of pain
Ophthalmic Surgery

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Ketorolac Tromethamine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ketorolac Tromethamine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ketorolac Tromethamine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Ketorolac Tromethamine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ketorolac Tromethamine introduction, etc. Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Ketorolac Tromethamine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Ketorolac Tromethamine Market Overview
1.1 Ketorolac Tromethamine Product Overview
1.2 Ketorolac Tromethamine Market Segment by Type
1.2.1 Injection
1.2.2 Ophthalmic
1.2.3 Nasal
1.2.4 Oral tablet
1.3 Global Ketorolac Tromethamine Market Size by Type
1.3.1 Global Ketorolac Tromethamine Market Size Overview by Type (2018-2034)
1.3.2 Global Ketorolac Tromethamine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Ketorolac Tromethamine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Ketorolac Tromethamine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Ketorolac Tromethamine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Ketorolac Tromethamine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Ketorolac Tromethamine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Ketorolac Tromethamine Sales Breakdown by Type (2018-2024)
2 Global Ketorolac Tromethamine Market Competition by Company
2.1 Global Top Players by Ketorolac Tromethamine Sales (2018-2024)
2.2 Global Top Players by Ketorolac Tromethamine Revenue (2018-2024)
2.3 Global Top Players by Ketorolac Tromethamine Price (2018-2024)
2.4 Global Top Manufacturers Ketorolac Tromethamine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Ketorolac Tromethamine Market Competitive Situation and Trends
2.5.1 Ketorolac Tromethamine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Ketorolac Tromethamine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ketorolac Tromethamine as of 2022)
2.7 Date of Key Manufacturers Enter into Ketorolac Tromethamine Market
2.8 Key Manufacturers Ketorolac Tromethamine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Ketorolac Tromethamine Status and Outlook by Region
3.1 Global Ketorolac Tromethamine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Ketorolac Tromethamine Historic Market Size by Region
3.2.1 Global Ketorolac Tromethamine Sales in Volume by Region (2018-2024)
3.2.2 Global Ketorolac Tromethamine Sales in Value by Region (2018-2024)
3.2.3 Global Ketorolac Tromethamine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Ketorolac Tromethamine Forecasted Market Size by Region
3.3.1 Global Ketorolac Tromethamine Sales in Volume by Region (2024-2034)
3.3.2 Global Ketorolac Tromethamine Sales in Value by Region (2024-2034)
3.3.3 Global Ketorolac Tromethamine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Ketorolac Tromethamine by Application
4.1 Ketorolac Tromethamine Market Segment by Application
4.1.1 Short-term treatment of pain
4.1.2 Ophthalmic Surgery
4.2 Global Ketorolac Tromethamine Market Size by Application
4.2.1 Global Ketorolac Tromethamine Market Size Overview by Application (2018-2034)
4.2.2 Global Ketorolac Tromethamine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Ketorolac Tromethamine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Ketorolac Tromethamine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Ketorolac Tromethamine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Ketorolac Tromethamine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Ketorolac Tromethamine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Ketorolac Tromethamine Sales Breakdown by Application (2018-2024)
5 North America Ketorolac Tromethamine by Country
5.1 North America Ketorolac Tromethamine Historic Market Size by Country
5.1.1 North America Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Ketorolac Tromethamine Sales in Volume by Country (2018-2024)
5.1.3 North America Ketorolac Tromethamine Sales in Value by Country (2018-2024)
5.2 North America Ketorolac Tromethamine Forecasted Market Size by Country
5.2.1 North America Ketorolac Tromethamine Sales in Volume by Country (2024-2034)
5.2.2 North America Ketorolac Tromethamine Sales in Value by Country (2024-2034)
6 Europe Ketorolac Tromethamine by Country
6.1 Europe Ketorolac Tromethamine Historic Market Size by Country
6.1.1 Europe Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Ketorolac Tromethamine Sales in Volume by Country (2018-2024)
6.1.3 Europe Ketorolac Tromethamine Sales in Value by Country (2018-2024)
6.2 Europe Ketorolac Tromethamine Forecasted Market Size by Country
6.2.1 Europe Ketorolac Tromethamine Sales in Volume by Country (2024-2034)
6.2.2 Europe Ketorolac Tromethamine Sales in Value by Country (2024-2034)
7 Asia-Pacific Ketorolac Tromethamine by Region
7.1 Asia-Pacific Ketorolac Tromethamine Historic Market Size by Region
7.1.1 Asia-Pacific Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Ketorolac Tromethamine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Ketorolac Tromethamine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Ketorolac Tromethamine Forecasted Market Size by Region
7.2.1 Asia-Pacific Ketorolac Tromethamine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Ketorolac Tromethamine Sales in Value by Region (2024-2034)
8 Latin America Ketorolac Tromethamine by Country
8.1 Latin America Ketorolac Tromethamine Historic Market Size by Country
8.1.1 Latin America Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Ketorolac Tromethamine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Ketorolac Tromethamine Sales in Value by Country (2018-2024)
8.2 Latin America Ketorolac Tromethamine Forecasted Market Size by Country
8.2.1 Latin America Ketorolac Tromethamine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Ketorolac Tromethamine Sales in Value by Country (2024-2034)
9 Middle East and Africa Ketorolac Tromethamine by Country
9.1 Middle East and Africa Ketorolac Tromethamine Historic Market Size by Country
9.1.1 Middle East and Africa Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Ketorolac Tromethamine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Ketorolac Tromethamine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Ketorolac Tromethamine Forecasted Market Size by Country
9.2.1 Middle East and Africa Ketorolac Tromethamine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Ketorolac Tromethamine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Ketorolac Tromethamine Products Offered
10.1.5 Pfizer Recent Development
10.2 Omeros Corporation
10.2.1 Omeros Corporation Company Information
10.2.2 Omeros Corporation Introduction and Business Overview
10.2.3 Omeros Corporation Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Omeros Corporation Ketorolac Tromethamine Products Offered
10.2.5 Omeros Corporation Recent Development
10.3 Egalet US Inc.
10.3.1 Egalet US Inc. Company Information
10.3.2 Egalet US Inc. Introduction and Business Overview
10.3.3 Egalet US Inc. Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Egalet US Inc. Ketorolac Tromethamine Products Offered
10.3.5 Egalet US Inc. Recent Development
10.4 Allergan
10.4.1 Allergan Company Information
10.4.2 Allergan Introduction and Business Overview
10.4.3 Allergan Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Allergan Ketorolac Tromethamine Products Offered
10.4.5 Allergan Recent Development
10.5 Dr. Reddy’s Laboratories
10.5.1 Dr. Reddy’s Laboratories Company Information
10.5.2 Dr. Reddy’s Laboratories Introduction and Business Overview
10.5.3 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Dr. Reddy’s Laboratories Ketorolac Tromethamine Products Offered
10.5.5 Dr. Reddy’s Laboratories Recent Development
10.6 Teva
10.6.1 Teva Company Information
10.6.2 Teva Introduction and Business Overview
10.6.3 Teva Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Teva Ketorolac Tromethamine Products Offered
10.6.5 Teva Recent Development
10.7 Mylan
10.7.1 Mylan Company Information
10.7.2 Mylan Introduction and Business Overview
10.7.3 Mylan Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Mylan Ketorolac Tromethamine Products Offered
10.7.5 Mylan Recent Development
10.8 West Ward Pharmaceuticals
10.8.1 West Ward Pharmaceuticals Company Information
10.8.2 West Ward Pharmaceuticals Introduction and Business Overview
10.8.3 West Ward Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 West Ward Pharmaceuticals Ketorolac Tromethamine Products Offered
10.8.5 West Ward Pharmaceuticals Recent Development
10.9 Fresenius Kabi
10.9.1 Fresenius Kabi Company Information
10.9.2 Fresenius Kabi Introduction and Business Overview
10.9.3 Fresenius Kabi Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Fresenius Kabi Ketorolac Tromethamine Products Offered
10.9.5 Fresenius Kabi Recent Development
10.10 Apotex
10.10.1 Apotex Company Information
10.10.2 Apotex Introduction and Business Overview
10.10.3 Apotex Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Apotex Ketorolac Tromethamine Products Offered
10.10.5 Apotex Recent Development
10.11 Sandoz
10.11.1 Sandoz Company Information
10.11.2 Sandoz Introduction and Business Overview
10.11.3 Sandoz Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Sandoz Ketorolac Tromethamine Products Offered
10.11.5 Sandoz Recent Development
10.12 Amphastar Pharmaceuticals
10.12.1 Amphastar Pharmaceuticals Company Information
10.12.2 Amphastar Pharmaceuticals Introduction and Business Overview
10.12.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Amphastar Pharmaceuticals Ketorolac Tromethamine Products Offered
10.12.5 Amphastar Pharmaceuticals Recent Development
10.13 Gland Pharma Limited
10.13.1 Gland Pharma Limited Company Information
10.13.2 Gland Pharma Limited Introduction and Business Overview
10.13.3 Gland Pharma Limited Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Gland Pharma Limited Ketorolac Tromethamine Products Offered
10.13.5 Gland Pharma Limited Recent Development
10.14 Akorn
10.14.1 Akorn Company Information
10.14.2 Akorn Introduction and Business Overview
10.14.3 Akorn Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Akorn Ketorolac Tromethamine Products Offered
10.14.5 Akorn Recent Development
10.15 Sun Pharmaceutical
10.15.1 Sun Pharmaceutical Company Information
10.15.2 Sun Pharmaceutical Introduction and Business Overview
10.15.3 Sun Pharmaceutical Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Sun Pharmaceutical Ketorolac Tromethamine Products Offered
10.15.5 Sun Pharmaceutical Recent Development
10.16 Sagent Pharmaceuticals
10.16.1 Sagent Pharmaceuticals Company Information
10.16.2 Sagent Pharmaceuticals Introduction and Business Overview
10.16.3 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Sagent Pharmaceuticals Ketorolac Tromethamine Products Offered
10.16.5 Sagent Pharmaceuticals Recent Development
10.17 Aurobindo Pharma
10.17.1 Aurobindo Pharma Company Information
10.17.2 Aurobindo Pharma Introduction and Business Overview
10.17.3 Aurobindo Pharma Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Aurobindo Pharma Ketorolac Tromethamine Products Offered
10.17.5 Aurobindo Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Ketorolac Tromethamine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Ketorolac Tromethamine Industrial Chain Analysis
11.4 Ketorolac Tromethamine Market Dynamics
11.4.1 Ketorolac Tromethamine Industry Trends
11.4.2 Ketorolac Tromethamine Market Drivers
11.4.3 Ketorolac Tromethamine Market Challenges
11.4.4 Ketorolac Tromethamine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Ketorolac Tromethamine Distributors
12.3 Ketorolac Tromethamine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Injection
Table 2. Major Company of Ophthalmic
Table 3. Major Company of Nasal
Table 4. Major Company of Oral tablet
Table 5. Global Ketorolac Tromethamine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Ketorolac Tromethamine Sales by Type (2018-2024) & (K Units)
Table 7. Global Ketorolac Tromethamine Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Ketorolac Tromethamine Sales by Type (2018-2024) & (US& Million)
Table 9. Global Ketorolac Tromethamine Market Share in Value by Type (2018-2024)
Table 10. Global Ketorolac Tromethamine Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Ketorolac Tromethamine Sales by Type (2024-2034) & (K Units)
Table 12. Global Ketorolac Tromethamine Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Ketorolac Tromethamine Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Ketorolac Tromethamine Sales Market Share in Value by Type (2024-2034)
Table 15. Global Ketorolac Tromethamine Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Ketorolac Tromethamine Sales by Type (2018-2024) & (K Units)
Table 17. North America Ketorolac Tromethamine Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Ketorolac Tromethamine Sales (K Units) by Type (2018-2024)
Table 19. Europe Ketorolac Tromethamine Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Ketorolac Tromethamine Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Ketorolac Tromethamine Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Ketorolac Tromethamine Sales (K Units) by Type (2018-2024)
Table 23. Latin America Ketorolac Tromethamine Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Ketorolac Tromethamine Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Ketorolac Tromethamine Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Ketorolac Tromethamine Sales by Company (2018-2024) & (K Units)
Table 27. Global Ketorolac Tromethamine Sales Share by Company (2018-2024)
Table 28. Global Ketorolac Tromethamine Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Ketorolac Tromethamine Revenue Share by Company (2018-2024)
Table 30. Global Market Ketorolac Tromethamine Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Ketorolac Tromethamine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Ketorolac Tromethamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ketorolac Tromethamine as of 2022)
Table 34. Date of Key Manufacturers Enter into Ketorolac Tromethamine Market
Table 35. Key Manufacturers Ketorolac Tromethamine Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Ketorolac Tromethamine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Ketorolac Tromethamine Sales by Region (2018-2024) & (K Units)
Table 39. Global Ketorolac Tromethamine Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Ketorolac Tromethamine Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Ketorolac Tromethamine Sales Market Share in Value by Region (2018-2024)
Table 42. Global Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Ketorolac Tromethamine Sales by Region (2024-2034) & (K Units)
Table 44. Global Ketorolac Tromethamine Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Ketorolac Tromethamine Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Ketorolac Tromethamine Sales Market Share in Value by Region (2024-2034)
Table 47. Global Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Ketorolac Tromethamine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Ketorolac Tromethamine Sales by Application (2018-2024) & (K Units)
Table 50. Global Ketorolac Tromethamine Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Ketorolac Tromethamine Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Ketorolac Tromethamine Sales Market Share in Value by Application (2018-2024)
Table 53. Global Ketorolac Tromethamine Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Ketorolac Tromethamine Sales by Application (2024-2034) & (K Units)
Table 55. Global Ketorolac Tromethamine Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Ketorolac Tromethamine Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Ketorolac Tromethamine Sales Market Share in Value by Application (2024-2034)
Table 58. Global Ketorolac Tromethamine Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Ketorolac Tromethamine Sales by Application (2018-2024) (K Units)
Table 60. North America Ketorolac Tromethamine Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Ketorolac Tromethamine Sales by Application (2018-2024) (K Units)
Table 62. Europe Ketorolac Tromethamine Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Ketorolac Tromethamine Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Ketorolac Tromethamine Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Ketorolac Tromethamine Sales by Application (2018-2024) (K Units)
Table 66. Latin America Ketorolac Tromethamine Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Ketorolac Tromethamine Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Ketorolac Tromethamine Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Ketorolac Tromethamine Sales by Country (2018-2024) & (K Units)
Table 70. North America Ketorolac Tromethamine Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Ketorolac Tromethamine Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Ketorolac Tromethamine Sales Market Share in Value by Country (2018-2024)
Table 73. North America Ketorolac Tromethamine Sales by Country (2024-2034) & (K Units)
Table 74. North America Ketorolac Tromethamine Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Ketorolac Tromethamine Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Ketorolac Tromethamine Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Ketorolac Tromethamine Sales by Country (2018-2024) & (K Units)
Table 78. Europe Ketorolac Tromethamine Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Ketorolac Tromethamine Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Ketorolac Tromethamine Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Ketorolac Tromethamine Sales by Country (2024-2034) & (K Units)
Table 82. Europe Ketorolac Tromethamine Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Ketorolac Tromethamine Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Ketorolac Tromethamine Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Ketorolac Tromethamine Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Ketorolac Tromethamine Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Ketorolac Tromethamine Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Ketorolac Tromethamine Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Ketorolac Tromethamine Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Ketorolac Tromethamine Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Ketorolac Tromethamine Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Ketorolac Tromethamine Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Ketorolac Tromethamine Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Ketorolac Tromethamine Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Ketorolac Tromethamine Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Ketorolac Tromethamine Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Ketorolac Tromethamine Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Ketorolac Tromethamine Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Ketorolac Tromethamine Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Ketorolac Tromethamine Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Ketorolac Tromethamine Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Ketorolac Tromethamine Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Ketorolac Tromethamine Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Ketorolac Tromethamine Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Ketorolac Tromethamine Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Ketorolac Tromethamine Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Ketorolac Tromethamine Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Ketorolac Tromethamine Sales Market Share in Value by Country (2024-2034)
Table 109. Pfizer Company Information
Table 110. Pfizer Introduction and Business Overview
Table 111. Pfizer Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Pfizer Ketorolac Tromethamine Product
Table 113. Pfizer Recent Development
Table 114. Omeros Corporation Company Information
Table 115. Omeros Corporation Introduction and Business Overview
Table 116. Omeros Corporation Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Omeros Corporation Ketorolac Tromethamine Product
Table 118. Omeros Corporation Recent Development
Table 119. Egalet US Inc. Company Information
Table 120. Egalet US Inc. Introduction and Business Overview
Table 121. Egalet US Inc. Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Egalet US Inc. Ketorolac Tromethamine Product
Table 123. Egalet US Inc. Recent Development
Table 124. Allergan Company Information
Table 125. Allergan Introduction and Business Overview
Table 126. Allergan Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Allergan Ketorolac Tromethamine Product
Table 128. Allergan Recent Development
Table 129. Dr. Reddy’s Laboratories Company Information
Table 130. Dr. Reddy’s Laboratories Introduction and Business Overview
Table 131. Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Dr. Reddy’s Laboratories Ketorolac Tromethamine Product
Table 133. Dr. Reddy’s Laboratories Recent Development
Table 134. Teva Company Information
Table 135. Teva Introduction and Business Overview
Table 136. Teva Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Teva Ketorolac Tromethamine Product
Table 138. Teva Recent Development
Table 139. Mylan Company Information
Table 140. Mylan Introduction and Business Overview
Table 141. Mylan Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Mylan Ketorolac Tromethamine Product
Table 143. Mylan Recent Development
Table 144. West Ward Pharmaceuticals Company Information
Table 145. West Ward Pharmaceuticals Introduction and Business Overview
Table 146. West Ward Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. West Ward Pharmaceuticals Ketorolac Tromethamine Product
Table 148. West Ward Pharmaceuticals Recent Development
Table 149. Fresenius Kabi Company Information
Table 150. Fresenius Kabi Introduction and Business Overview
Table 151. Fresenius Kabi Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. Fresenius Kabi Ketorolac Tromethamine Product
Table 153. Fresenius Kabi Recent Development
Table 154. Apotex Company Information
Table 155. Apotex Introduction and Business Overview
Table 156. Apotex Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. Apotex Ketorolac Tromethamine Product
Table 158. Apotex Recent Development
Table 159. Sandoz Company Information
Table 160. Sandoz Introduction and Business Overview
Table 161. Sandoz Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 162. Sandoz Ketorolac Tromethamine Product
Table 163. Sandoz Recent Development
Table 164. Amphastar Pharmaceuticals Company Information
Table 165. Amphastar Pharmaceuticals Introduction and Business Overview
Table 166. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 167. Amphastar Pharmaceuticals Ketorolac Tromethamine Product
Table 168. Amphastar Pharmaceuticals Recent Development
Table 169. Gland Pharma Limited Company Information
Table 170. Gland Pharma Limited Introduction and Business Overview
Table 171. Gland Pharma Limited Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 172. Gland Pharma Limited Ketorolac Tromethamine Product
Table 173. Gland Pharma Limited Recent Development
Table 174. Akorn Company Information
Table 175. Akorn Introduction and Business Overview
Table 176. Akorn Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 177. Akorn Ketorolac Tromethamine Product
Table 178. Akorn Recent Development
Table 179. Sun Pharmaceutical Company Information
Table 180. Sun Pharmaceutical Introduction and Business Overview
Table 181. Sun Pharmaceutical Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 182. Sun Pharmaceutical Ketorolac Tromethamine Product
Table 183. Sun Pharmaceutical Recent Development
Table 184. Sagent Pharmaceuticals Company Information
Table 185. Sagent Pharmaceuticals Introduction and Business Overview
Table 186. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 187. Sagent Pharmaceuticals Ketorolac Tromethamine Product
Table 188. Sagent Pharmaceuticals Recent Development
Table 189. Aurobindo Pharma Company Information
Table 190. Aurobindo Pharma Introduction and Business Overview
Table 191. Aurobindo Pharma Ketorolac Tromethamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 192. Aurobindo Pharma Ketorolac Tromethamine Product
Table 193. Aurobindo Pharma Recent Development
Table 194. Key Raw Materials Lists
Table 195. Raw Materials Key Suppliers Lists
Table 196. Ketorolac Tromethamine Market Trends
Table 197. Ketorolac Tromethamine Market Drivers
Table 198. Ketorolac Tromethamine Market Challenges
Table 199. Ketorolac Tromethamine Market Restraints
Table 200. Ketorolac Tromethamine Distributors List
Table 201. Ketorolac Tromethamine Downstream Customers
Table 202. Research Programs/Design for This Report
Table 203. Key Data Information from Secondary Sources
Table 204. Key Data Information from Primary Sources
List of Figures
Figure 1. Ketorolac Tromethamine Product Picture
Figure 2. Global Ketorolac Tromethamine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Ketorolac Tromethamine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Ketorolac Tromethamine Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Injection
Figure 6. Global Injection Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Ophthalmic
Figure 8. Global Ophthalmic Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Nasal
Figure 10. Global Nasal Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Oral tablet
Figure 12. Global Oral tablet Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Ketorolac Tromethamine Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Ketorolac Tromethamine Sales Market Share by Type in 2022 & 2034
Figure 15. North America Ketorolac Tromethamine Sales Market Share in Volume by Type in 2022
Figure 16. North America Ketorolac Tromethamine Sales Market Share in Value by Type in 2022
Figure 17. Europe Ketorolac Tromethamine Sales Market Share in Volume by Type in 2022
Figure 18. Europe Ketorolac Tromethamine Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Ketorolac Tromethamine Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Ketorolac Tromethamine Sales Market Share in Value by Type in 2022
Figure 21. Latin America Ketorolac Tromethamine Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Ketorolac Tromethamine Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Ketorolac Tromethamine Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Ketorolac Tromethamine Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Ketorolac Tromethamine Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Ketorolac Tromethamine Revenue in 2022
Figure 27. Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Short-term treatment of pain
Figure 29. Global Short-term treatment of pain Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Ophthalmic Surgery
Figure 31. Global Ophthalmic Surgery Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Global Ketorolac Tromethamine Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Ketorolac Tromethamine Sales Market Share by Application in 2022 & 2034
Figure 34. North America Ketorolac Tromethamine Sales Market Share in Volume by Application in 2022
Figure 35. North America Ketorolac Tromethamine Sales Market Share in Value by Application in 2022
Figure 36. Europe Ketorolac Tromethamine Sales Market Share in Volume by Application in 2022
Figure 37. Europe Ketorolac Tromethamine Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Ketorolac Tromethamine Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Ketorolac Tromethamine Sales Market Share in Value by Application in 2022
Figure 40. Latin America Ketorolac Tromethamine Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Ketorolac Tromethamine Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Ketorolac Tromethamine Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Ketorolac Tromethamine Manufacturing Cost Structure
Figure 45. Ketorolac Tromethamine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries